Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”

June 14, 2021

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren’t any new results

Optional text in email:

Additional articles :

Endo-TLIF versus MIS-TLIF in 1-segment lumbar spondylolisthesis: A prospective randomized pilot stud...

Image-Guided Percutaneous Multilevel Pediculosynthesis for the Treatment of Contiguous Pedicle Stres...

A Simple Preoperative Score Predicting Failure Following Decompression Surgery for Degenerative Lumb...

Incidence and risk factors of proximal junctional kyphosis after internal fixation for adult spinal ...

The Incidence of Venous Thromboembolism in Patients Undergoing Anterior Lumbar Interbody Fusion: A P...